首页 | 本学科首页   官方微博 | 高级检索  
     


Rare Breast Cancer Subtypes: Histological,Molecular, and Clinical Peculiarities
Authors:Maria Vittoria Dieci  Enrico Orvieto  Massimo Dominici  PierFranco Conte  Valentina Guarneri
Affiliation:1. Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy;2. and Istituto Oncologico Veneto IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Padova, Italy;3. Department of Pathology, University Hospital of Padova, Padova, Italy;4. Department of Medical and Surgical Sciences for Children & Adults, University of Modena and Reggio Emilia, Modena, Italy
Abstract:Breast cancer encompasses a collection of different diseases characterized by different biological and pathological features, clinical presentation, response to treatments, clinical behavior, and outcome. On the basis of cell morphology, growth, and architecture patterns, breast cancer can be classified in up to 21 distinct histological types. Breast cancer special types, including the classic lobular invasive carcinoma, represent 25% of all breast cancers. The histological diversity of breast carcinomas has relevant prognostic implications. Indeed, the rare breast cancer group includes subtypes with very different prognoses, ranging from the tubular carcinoma, associated with an indolent clinical course, to metaplastic cancer, whose outcome is generally unfavorable. New approaches based on gene expression profiling allow the identification of molecularly defined breast cancer classes, with distinct biological features and clinical behavior. In clinical practice, immunohistochemical classification based on the expression of human epidermal growth factor receptor 2 and Ki67 is applied as a surrogate of the intrinsic molecular subtypes. However, the identification of intrinsic molecular subtypes were almost completely limited to the study of ductal invasive breast cancer. Moreover, some good‐prognosis triple‐negative histotypes, on the basis of gene expression profiling, can be classified among the poor‐prognosis group. Therefore, histopathological classification remains a crucial component of breast cancer diagnosis. Special histologies can be very rare, and the majority of information on outcome and treatments derives from small series and case reports. As a consequence, clear recommendations about clinical management are still lacking. In this review, we summarize current knowledge about rare breast cancer histologies.
Keywords:Mucinous carcinoma  Tubular carcinoma  Medullary carcinoma  Metaplastic carcinoma  Pleomorphic lobular cancer  Cribriform carcinoma
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号